Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Eli Lilly and Company (LLY)

113.17   0.37 (0.33%) 11-12 16:03
Open: 112.77 Pre. Close: 112.8
High: 114.04 Low: 112.45
Volume: 2,229,901 Market Cap: 108658M
Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 114.146 - 114.699 114.699 - 115.177
Low: 111.115 - 111.759 111.759 - 112.315
Close: 112.211 - 113.204 113.204 - 114.061

Technical analysis

as of: 2019-11-12 4:29:24 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 133.93     One year: 156.44
Support: Support1: 106.44    Support2: 101.36
Resistance: Resistance1: 114.67    Resistance2: 133.93
Pivot: 111.98
Moving Average: MA(5): 113.22     MA(20): 111.13
MA(100): 111.02     MA(250): 115.52
MACD: MACD(12,26): 0.91     Signal(9): 0.68
Stochastic oscillator: %K(14,3): 88.71     %D(3): 88.89
RSI: RSI(14): 55.56
52-week: High: 132.13  Low: 101.36  Change(%): 0.7
Average Vol(K): 3-Month: 314319  10-Days: 288115

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
LLY has closed below upper band by 34.8%. Bollinger Bands are 6.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 12 Nov 2019 15:05:24 +0000
Ex-Dividend Reminder: Allete, American States Water and Eli Lilly

Thu, 07 Nov 2019 15:06:07 +0000
3 Top Diabetes Stocks to Watch in November

Wed, 06 Nov 2019 15:07:29 +0000
Why the Opioid Crisis Makes Vertex Pharmaceuticals a Buy

Fri, 01 Nov 2019 20:24:18 +0000
WeWork IPO was a Failure – These 2 IPO Stocks are Surging

Tue, 29 Oct 2019 14:12:00 +0000
Can New Drugs Help Gilead Sciences Rebound?

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 960.13
Shares Float (M) 842.07
% Held by Insiders 0.12
% Held by Institutions 81.46
Shares Short (K) 13510
Shares Short P. Month (K)

Stock Financials

EPS 8.260
Book Value (p.s.) 3.720
PEG Ratio 1.84
Profit Margin 31.91
Operating Margin 25.25
Return on Assets (ttm) 9.5
Return on Equity (ttm) 49.3
Qtrly Rev. Growth 3.2
Gross Profit (p.s.) 18.883
Sales Per Share
EBITDA (p.s.) 7.666
Qtrly Earnings Growth 9.10
Operating Cash Flow (M) 4320.00
Levered Free Cash Flow (M) 3570.00

Stock Valuations

P/E 13.70
P/E Growth Ratio
P/BV 30.42
P/S 4.34
P/CF 25.15

Dividends & Splits

Dividend 2.500
Dividend Yield 0.02
Dividend Pay Date 2019-12-10
Ex-Dividend Date 2019-11-14
Forward Dividend 2.580
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.